ERD

Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19

Full project page

Organisations map overview

JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN - (Coördinator)

Country:

ACADEMISCH ZIEKENHUIS GRONINGEN

Country:

ACADEMISCH ZIEKENHUIS MAASTRICHT

Country:

ACCELOPMENT AG

Country:

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

Country:

CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA EPE

Country:

EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL

Country:

F4-PHARMA GES M B H

Country:

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Country:

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE

Country:

INSTITUT CATALA DE LA SALUT

Country:

LIETUVOS SVEIKATOS MOKSLU UNIVERSITETO LIGONINE KAUNO KLINIKOS

Country:

MEDICAL INTELLIGENT DATA ANALYTICS

Country:

TAMPEREEN KORKEAKOULUSAATIO SR

Country:

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT

Country:

UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTI

Country:

University College Dublin (UCD)

Country:

Università degli Studi di Perugia

Country: